First Header Logo Second Header Logo

Connection

Michael Carstens to Humans

This is a "connection" page, showing publications Michael Carstens has written about Humans.
Connection Strength

0.266
  1. Carstens MH, Mendieta M, Pérez C, Villareal E, Garcia R. Assisted Salvage of Ischemic Fasciocutaneous Flap Using Adipose-Derived Mesenchymal Stem Cells: In-Situ Revascularization. Aesthet Surg J. 2017 07 01; 37(suppl_3):S38-S45.
    View in: PubMed
    Score: 0.034
  2. Carstens MH, Gómez A, Cortés R, Turner E, Pérez C, Ocon M, Correa D. Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells. Stem Cell Res. 2017 01; 18:14-21.
    View in: PubMed
    Score: 0.033
  3. Franco J, Coppage J, Carstens MH. Mandibular distraction using bone morphogenic protein and rapid distraction in neonates with Pierre Robin syndrome. J Craniofac Surg. 2010 Jul; 21(4):1158-61.
    View in: PubMed
    Score: 0.021
  4. Fallucco MA, Carstens MH. Primary reconstruction of alveolar clefts using recombinant human bone morphogenic protein-2: clinical and radiographic outcomes. J Craniofac Surg. 2009 Sep; 20 Suppl 2:1759-64.
    View in: PubMed
    Score: 0.020
  5. Tom WK, Chin M, Ng T, Bouchoucha S, Carstens M. Distraction of rhBMP-2-generated mandible: how stable is the engineered bone in response to subsequent surgeries? J Oral Maxillofac Surg. 2008 Jul; 66(7):1499-505.
    View in: PubMed
    Score: 0.018
  6. Carstens MH. Neural tube programming and the pathogenesis of craniofacial clefts, part I: the neuromeric organization of the head and neck. Handb Clin Neurol. 2008; 87:247-76.
    View in: PubMed
    Score: 0.018
  7. Carstens MH. Neural tube programming and the pathogenesis of craniofacial clefts, part II: mesenchyme, pharyngeal arches, developmental fields; and the assembly of the human face. Handb Clin Neurol. 2008; 87:277-339.
    View in: PubMed
    Score: 0.018
  8. Chao M, Donovan T, Sotelo C, Carstens MH. In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduction via stem cell concentration. J Craniofac Surg. 2006 May; 17(3):405-12.
    View in: PubMed
    Score: 0.016
  9. Carstens MH, Chin M, Ng T, Tom WK. Reconstruction of #7 facial cleft with distraction-assisted in situ osteogenesis (DISO): role of recombinant human bone morphogenetic protein-2 with Helistat-activated collagen implant. J Craniofac Surg. 2005 Nov; 16(6):1023-32.
    View in: PubMed
    Score: 0.015
  10. Carstens MH, Chin M, Li XJ. In situ osteogenesis: regeneration of 10-cm mandibular defect in porcine model using recombinant human bone morphogenetic protein-2 (rhBMP-2) and Helistat absorbable collagen sponge. J Craniofac Surg. 2005 Nov; 16(6):1033-42.
    View in: PubMed
    Score: 0.015
  11. Chin M, Ng T, Tom WK, Carstens M. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg. 2005 Sep; 16(5):778-89.
    View in: PubMed
    Score: 0.015
  12. Carstens MH. Functional matrix cleft repair: principles and techniques. Clin Plast Surg. 2004 Apr; 31(2):159-89, viii.
    View in: PubMed
    Score: 0.014
  13. Carstens MH. Neural tube programming and craniofacial cleft formation. I. The neuromeric organization of the head and neck. Eur J Paediatr Neurol. 2004; 8(4):181-210; discussion 179-80.
    View in: PubMed
    Score: 0.013
  14. Carstens MH. Development of the facial midline. J Craniofac Surg. 2002 Jan; 13(1):129-87; discussion 188-90.
    View in: PubMed
    Score: 0.012
  15. Frame JD, Still J, Lakhel-LeCoadou A, Carstens MH, Lorenz C, Orlet H, Spence R, Berger AC, Dantzer E, Burd A. Use of dermal regeneration template in contracture release procedures: a multicenter evaluation. Plast Reconstr Surg. 2004 Apr 15; 113(5):1330-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.